Latest Market Dynamics News

Litchfield Minerals refutes any undisclosed material information behind recent share price jumps, pointing to public engagement, ongoing assays, and market dynamics as drivers of volatility.

Brazilian Rare Earths Limited (ASX: BRE) is demerging its Amargosa Bauxite-Gallium Project into a new ASX-listed entity, Alurion Resources, aiming to unlock value and sharpen focus on distinct mineral opportunities.

Life360 has authorized a $225 million share repurchase program aimed at offsetting dilution from stock-based compensation, supported by robust cash flow and a strong balance sheet.

ALS Limited reported a 25.8% jump in underlying net profit after tax to AUD 381.2 million for FY26, driven by strong commodity testing demand and margin expansion. The company raised its dividend and advanced major hub lab projects while navigating a post-year-end cyber incident.

Kiwi Property Group reported FY26 results showing 4.3% rental income growth, a stronger balance sheet with gearing down to 37.4%, and a dividend increase, while progressing key asset sales and development projects.

Atomo Diagnostics has closed a modest Share Purchase Plan, raising $44,500 and issuing free attaching options, while reserving a substantial shortfall for future placement.

Advanced Energy Minerals is ramping up its Quebec high purity alumina plant to 3,000 tpa by mid-2026, with plans to double capacity to 6,000 tpa by 2029 amid a tightening global market and supply deficit.

Nelson Resources has staked 186 claims forming the Cinnamon Property in Nevada, next to Guardian Metal's Pilot Mountain tungsten project, positioning itself in a strategic US critical minerals district amid soaring tungsten prices and supply concerns.

Critical Resources has lodged an application to extend its Croesus gold-tungsten permit in New Zealand, targeting a broader tungsten system with historic grades up to 42.6% WO3. This move comes as tungsten prices surge over eightfold due to global supply constraints.

Barramundi Limited outperformed the S&P/ASX200 in April with a 4.4% gross return, boosted by NEXT DC’s landmark data centre deal and capital raise, while healthcare stocks faced headwinds from Cochlear’s profit downgrade.

Radius Residential Care delivered a standout FY26 with profit before tax surging 37% to $14.3 million, a 50% hike in its final dividend, and growth fueled by acquisitions and new developments.

Evion Group has secured an exclusive option to acquire a high-grade fluorspar project in Nevada, complementing its graphite assets and supported by a $6.5 million capital raise to fund US expansion and exploration.